'''Crystal structure of Staphylococcal Complement Inhibitor'''
===Crystal structure of Staphylococcal Complement Inhibitor===
==Overview==
<!--
The pathogenic bacterium Staphylococcus aureus counteracts the host immune defense by excretion of the 85 residue staphylococcal complement inhibitor (SCIN). SCIN inhibits the central complement convertases; thereby, it reduces phagocytosis following opsonization and efficiently blocks all downstream effector functions. In this study, we present the crystal structure of SCIN at 1.8 A resolution and the identification of its active site. Functional characterization of structure based chimeric proteins, consisting of SCIN and the structurally but nonfunctional homologue open reading frame-D, indicate an 18-residue segment (Leu-31-Gly-48) crucial for SCIN activity. In all complement activation pathways, chimeras lacking these SCIN residues completely fail to inhibit production of the potent mediator of inflammation C5a. Inhibition of alternative pathway-mediated opsonization (C3b deposition) and formation of the lytic membrane attack complex (C5b-9 deposition) are strongly reduced for these chimeras as well. For inhibition of the classical/lectin pathway-mediated C3b and C5b-9 deposition, the same residues are critical although additional sites are involved. These chimeras also display reduced capacity to stabilize the C3 convertases of both the alternative and the classical/lectin pathway indicating the stabilizing effect is pivotal for the complement inhibitory activity of SCIN. Because SCIN specifically and efficiently inhibits complement, it has a high potential in anti-inflammatory therapy. Our data are a first step toward the development of a second generation molecule suitable for such therapeutic complement intervention.
The line below this paragraph, {{ABSTRACT_PUBMED_17709514}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17709514 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17709514}}
==About this Structure==
==About this Structure==
Line 34:
Line 38:
[[Category: Inhibitor]]
[[Category: Inhibitor]]
[[Category: Molecular biology]]
[[Category: Molecular biology]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 14:52:07 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 00:11:44 2008''
Revision as of 21:11, 28 July 2008
This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.
